LEADER 01013nam0-2200337---450-
001 990008269100403321
005 20060228112346.0
010   $a0444872752
035   $a000826910
035   $aFED01000826910
035   $a(Aleph)000826910FED01
035   $a000826910
100   $a20060208d1988----km-y0itay50------ba
101 0 $aeng
102   $aGB
105   $aa-------001yy
200 1 $aAnthracycline and anthracenedione - based anticancer agents$fedited by J. William Lown
210   $aAmsterdam [etc.]$cElsevier$d1988
215   $aXX, 753 p.$d25 cm
225 1 $aBioactive molecules$v6
610 0 $aAntineoplastici$aFarmacologia
610 0 $aAntibiotici anticancerogeni$aFarmacologia
676   $a616.99
702  1$aLown,$bWilliam J.
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990008269100403321
952   $a80 XIV C 23 CFT (1)$bCTF$fFFABC
959   $aFFABC
996   $aAnthracycline and anthracenedione - based anticancer agents$9741131
997   $aUNINA

LEADER 00753nam0-22002771i-450-
001 990004970870403321
005 19990530
035   $a000497087
035   $aFED01000497087
035   $a(Aleph)000497087FED01
035   $a000497087
100   $a19990530g19499999km-y0itay50------ba
101 0 $aita
105   $ay-------001yy
200 1 $aAutobiograffa$fEdward Gibbon
210   $aBuenos Aires [etc.]$cEspasa-Calpe$dc1949.
215   $a162 p.$d18 cm
225 1 $aColección austral$v915
700  1$aGibbon,$bEdward$f<1737-1794>$0166636
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990004970870403321
952   $aYP 3 915$bFil. Mod. 7311$fFLFBC
959   $aFLFBC
996   $aAutobiograffa$9526088
997   $aUNINA